The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 22, 2013

Filed:

Feb. 16, 2010
Applicants:

Wilhelm Amberg, Ludwigshafen, DE;

Michael Ochse, Ludwigshafen, DE;

Udo Lange, Ludwigshafen, DE;

Andreas Kling, Ludwigshafen, DE;

Berthold Behl, Ludwigshafen, DE;

Wilfried Homberger, Ludwigshafen, DE;

Mario Mezler, Ludwigshafen, DE;

Charles W. Hutchins, Green Oaks, IL (US);

Inventors:

Wilhelm Amberg, Ludwigshafen, DE;

Michael Ochse, Ludwigshafen, DE;

Udo Lange, Ludwigshafen, DE;

Andreas Kling, Ludwigshafen, DE;

Berthold Behl, Ludwigshafen, DE;

Wilfried Homberger, Ludwigshafen, DE;

Mario Mezler, Ludwigshafen, DE;

Charles W. Hutchins, Green Oaks, IL (US);

Assignees:

AbbVie Deutschland GmbH & Co. KG, Wiesbaden, DE;

Abbott Laboratories, Abbott Park, IL (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/16 (2006.01); C07C 215/70 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to aminotetraline derivatives of the formula (I) or a physiologically tolerated salt thereof. The invention relates to pharmaceutical compositions comprising such aminotetraline derivatives, and the use of such aminotetraline derivatives for therapeutic purposes. The aminotetraline derivatives are GlyT1 inhibitors.


Find Patent Forward Citations

Loading…